angiotensin ii has been researched along with maxacalcitol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, K; Fujita, T; Shimosawa, T | 1 |
| Fujii, N; Hamano, T; Hirata, M; Inoue, K; Isaka, Y; Kusunoki, Y; Matsui, I; Nakano, C; Nishiyama, A; Rakugi, H; Shimomura, A; Takabatake, Y; Tsubakihara, Y | 1 |
2 other study(ies) available for angiotensin ii and maxacalcitol
| Article | Year |
|---|---|
Enhancement of vasoconstrictor response by a noncalcemic analogue of vitamin D3.
Topics: 24,25-Dihydroxyvitamin D 3; Angiotensin II; Animals; Blood Pressure; Calcitriol; Calcium; Dose-Response Relationship, Drug; Drug Synergism; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Vasoconstriction | 1993 |
Maxacalcitol ameliorates tubulointerstitial fibrosis in obstructed kidneys by recruiting PPM1A/VDR complex to pSmad3.
Topics: Angiotensin II; Animals; Base Sequence; Calcitriol; Cell Line; Extracellular Matrix Proteins; Fibrosis; Immunohistochemistry; Kidney Diseases; Kidney Tubules; Male; Molecular Sequence Data; Phosphoprotein Phosphatases; Phosphorylation; Protective Agents; Protein Phosphatase 2C; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, Calcitriol; Renin; RNA, Messenger; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Ureteral Obstruction | 2012 |